Global Age Related Macular Degeneration Drug Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Age Related Macular Degeneration Drug

• 1.1 Definition of Age Related Macular Degeneration Drug
• 1.2 Age Related Macular Degeneration Drug Segment by Type
  • 1.2.1 Global Age Related Macular Degeneration Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Lucentis
  • 1.2.3 Eylea
  • 1.2.4 Avastin
  • 1.2.5 Others
• 1.3 Age Related Macular Degeneration Drug Segment by Applications
  • 1.3.1 Global Age Related Macular Degeneration Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Clinic
  • 1.3.3 Hospital
  • 1.3.4 Others
• 1.4 Global Age Related Macular Degeneration Drug Overall Market
  • 1.4.1 Global Age Related Macular Degeneration Drug Revenue (2014-2025)
  • 1.4.2 Global Age Related Macular Degeneration Drug Production (2014-2025)
  • 1.4.3 North America Age Related Macular Degeneration Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Age Related Macular Degeneration Drug Status and Prospect (2014-2025)
  • 1.4.5 China Age Related Macular Degeneration Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Age Related Macular Degeneration Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Age Related Macular Degeneration Drug Status and Prospect (2014-2025)
  • 1.4.8 India Age Related Macular Degeneration Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Age Related Macular Degeneration Drug
• 2.3 Manufacturing Process Analysis of Age Related Macular Degeneration Drug
• 2.4 Industry Chain Structure of Age Related Macular Degeneration Drug

3 Development and Manufacturing Plants Analysis of Age Related Macular Degeneration Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Age Related Macular Degeneration Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Age Related Macular Degeneration Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Age Related Macular Degeneration Drug Production and Capacity Analysis
• 4.2 Age Related Macular Degeneration Drug Revenue Analysis
• 4.3 Age Related Macular Degeneration Drug Price Analysis
• 4.4 Market Concentration Degree

5 Age Related Macular Degeneration Drug Regional Market Analysis

• 5.1 Age Related Macular Degeneration Drug Production by Regions
  • 5.1.1 Global Age Related Macular Degeneration Drug Production by Regions
  • 5.1.2 Global Age Related Macular Degeneration Drug Revenue by Regions
• 5.2 Age Related Macular Degeneration Drug Consumption by Regions
• 5.3 North America Age Related Macular Degeneration Drug Market Analysis
  • 5.3.1 North America Age Related Macular Degeneration Drug Production
  • 5.3.2 North America Age Related Macular Degeneration Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Age Related Macular Degeneration Drug Import and Export
• 5.4 Europe Age Related Macular Degeneration Drug Market Analysis
  • 5.4.1 Europe Age Related Macular Degeneration Drug Production
  • 5.4.2 Europe Age Related Macular Degeneration Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Age Related Macular Degeneration Drug Import and Export
• 5.5 China Age Related Macular Degeneration Drug Market Analysis
  • 5.5.1 China Age Related Macular Degeneration Drug Production
  • 5.5.2 China Age Related Macular Degeneration Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Age Related Macular Degeneration Drug Import and Export
• 5.6 Japan Age Related Macular Degeneration Drug Market Analysis
  • 5.6.1 Japan Age Related Macular Degeneration Drug Production
  • 5.6.2 Japan Age Related Macular Degeneration Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Age Related Macular Degeneration Drug Import and Export
• 5.7 Southeast Asia Age Related Macular Degeneration Drug Market Analysis
  • 5.7.1 Southeast Asia Age Related Macular Degeneration Drug Production
  • 5.7.2 Southeast Asia Age Related Macular Degeneration Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Age Related Macular Degeneration Drug Import and Export
• 5.8 India Age Related Macular Degeneration Drug Market Analysis
  • 5.8.1 India Age Related Macular Degeneration Drug Production
  • 5.8.2 India Age Related Macular Degeneration Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Age Related Macular Degeneration Drug Import and Export

6 Age Related Macular Degeneration Drug Segment Market Analysis (by Type)

• 6.1 Global Age Related Macular Degeneration Drug Production by Type
• 6.2 Global Age Related Macular Degeneration Drug Revenue by Type
• 6.3 Age Related Macular Degeneration Drug Price by Type

7 Age Related Macular Degeneration Drug Segment Market Analysis (by Application)

• 7.1 Global Age Related Macular Degeneration Drug Consumption by Application
• 7.2 Global Age Related Macular Degeneration Drug Consumption Market Share by Application (2014-2019)

8 Age Related Macular Degeneration Drug Major Manufacturers Analysis

• 8.1 Applied Genetic Technologies Corp
  • 8.1.1 Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Production Sites and Area Served
  • 8.1.2 Applied Genetic Technologies Corp Product Introduction, Application and Specification
  • 8.1.3 Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Astellas Pharma Inc
  • 8.2.1 Astellas Pharma Inc Age Related Macular Degeneration Drug Production Sites and Area Served
  • 8.2.2 Astellas Pharma Inc Product Introduction, Application and Specification
  • 8.2.3 Astellas Pharma Inc Age Related Macular Degeneration Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Benitec Biopharma Ltd
  • 8.3.1 Benitec Biopharma Ltd Age Related Macular Degeneration Drug Production Sites and Area Served
  • 8.3.2 Benitec Biopharma Ltd Product Introduction, Application and Specification
  • 8.3.3 Benitec Biopharma Ltd Age Related Macular Degeneration Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Biokine Therapeutics Ltd
  • 8.4.1 Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Production Sites and Area Served
  • 8.4.2 Biokine Therapeutics Ltd Product Introduction, Application and Specification
  • 8.4.3 Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Crinetics Pharmaceuticals Inc
  • 8.5.1 Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Production Sites and Area Served
  • 8.5.2 Crinetics Pharmaceuticals Inc Product Introduction, Application and Specification
  • 8.5.3 Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Critical Pharmaceuticals Ltd
  • 8.6.1 Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Production Sites and Area Served
  • 8.6.2 Critical Pharmaceuticals Ltd Product Introduction, Application and Specification
  • 8.6.3 Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Daiichi Sankyo Company Ltd
  • 8.7.1 Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Production Sites and Area Served
  • 8.7.2 Daiichi Sankyo Company Ltd Product Introduction, Application and Specification
  • 8.7.3 Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Diffusion Pharmaceuticals Inc
  • 8.8.1 Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Production Sites and Area Served
  • 8.8.2 Diffusion Pharmaceuticals Inc Product Introduction, Application and Specification
  • 8.8.3 Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Dong-A Socio Holdings Co Ltd
  • 8.9.1 Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Production Sites and Area Served
  • 8.9.2 Dong-A Socio Holdings Co Ltd Product Introduction, Application and Specification
  • 8.9.3 Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Eleven Biotherapeutics Inc
  • 8.10.1 Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Production Sites and Area Served
  • 8.10.2 Eleven Biotherapeutics Inc Product Introduction, Application and Specification
  • 8.10.3 Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Elsalys Biotech SAS
• 8.12 Lupin Ltd
• 8.13 M's Science Corp
• 8.14 Mabion SA
• 8.15 MacuCLEAR Inc

9 Development Trend of Analysis of Age Related Macular Degeneration Drug Market

• 9.1 Global Age Related Macular Degeneration Drug Market Trend Analysis
  • 9.1.1 Global Age Related Macular Degeneration Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Age Related Macular Degeneration Drug Regional Market Trend
  • 9.2.1 North America Age Related Macular Degeneration Drug Forecast 2019-2025
  • 9.2.2 Europe Age Related Macular Degeneration Drug Forecast 2019-2025
  • 9.2.3 China Age Related Macular Degeneration Drug Forecast 2019-2025
  • 9.2.4 Japan Age Related Macular Degeneration Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Age Related Macular Degeneration Drug Forecast 2019-2025
  • 9.2.6 India Age Related Macular Degeneration Drug Forecast 2019-2025
• 9.3 Age Related Macular Degeneration Drug Market Trend (Product Type)
• 9.4 Age Related Macular Degeneration Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Age Related Macular Degeneration Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List